Cargando…
Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly
BACKGROUND: Histone deacetylase (HDAC) inhibitors are currently undergoing clinical evaluation as anti-cancer agents. Dietary constituents share certain properties of HDAC inhibitor drugs, including the ability to induce global histone acetylation, turn-on epigenetically-silenced genes, and trigger...
Autores principales: | Rajendran, Praveen, Delage, Barbara, Dashwood, W Mohaiza, Yu, Tian-Wei, Wuth, Bradyn, Williams, David E, Ho, Emily, Dashwood, Roderick H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127849/ https://www.ncbi.nlm.nih.gov/pubmed/21624135 http://dx.doi.org/10.1186/1476-4598-10-68 |
Ejemplares similares
-
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates
por: Rajendran, Praveen, et al.
Publicado: (2013) -
Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon
por: Rajendran, Praveen, et al.
Publicado: (2015) -
Structural Characterization of the SMRT Corepressor Interacting with Histone Deacetylase 7
por: Desravines, Danielle C., et al.
Publicado: (2017) -
Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT
por: Stanya, Kristopher J., et al.
Publicado: (2008) -
Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4
por: Park, Suk-Youl, et al.
Publicado: (2018)